                      Hypoxia-Inducible Factors
                     in Physiology and Medicine




           Gregg L. Semenza, M.D., Ph.D.
    Vascular Program, Institute for Cell Engineering;
Departments of Genetic Medicine, Pediatrics, Oncology,
Medicine, Radiation Oncology, and Biological Chemistry;
      Johns Hopkins University School of Medicine
               Baltimore, Maryland USA


Oxygen Homeostasis: A Balancing Act




                                         O2 Supply

                                           Blood
O2 Demand
                                           Heart

                                        Blood Vessels

                                           Lungs

                                            CNS
            Hypoxia-Inducible Factors


Control of Red Blood Cell Production




      Cardiovascular Disease




              Cancer


Control of Red Blood Cell Production




      Cardiovascular Disease




              Cancer


    Erythropoietin Controls Red Blood Cell Production




               Erythropoietin (EPO)
 Bone
marrow




                                                O2 delivery
                                                to every cell
                                                In the body


    Erythropoietin Controls Red Blood Cell Production




                                                Chronic
                                                Kidney Disease

               Erythropoietin (EPO)
 Bone
marrow




                                                O2 delivery
                                                to every cell
                                                In the body


    Erythropoietin Controls Red Blood Cell Production
        What Controls Erythropoietin Production?



                                      ?
                                                Chronic
                                                Kidney Disease

               Erythropoietin (EPO)
 Bone
marrow




                                                O2 delivery
                                                to every cell
                                                In the body


Hypoxia-Inducible Factor 1 (HIF-1) Binds to the EPO Gene
               and Activates Transcription




                                                                          Hypoxia
                                          HATs                            Response
                                                                          Element




          G. L. Semenza and G. L. Wang, Mol. Cell. Biol. 12: 5447, 1992
          G. L. Wang and G. L. Semenza, J. Biol. Chem. 270: 1230, 1995
           G. L. Wang et al. Proc. Natl. Acad. Sci. USA 92: 5510, 1995


    HIF-1α is Regulated by Oxygen-dependent Hydroxylation
                                  CO2 + succinate


                                  O2 +
                                  α-ketoglutarate




PHDs = Prolyl Hydroxylase Domain proteins target HIF-1α for destruction when O2 is available.


  HIF-1α Protein Accumulates in Response to Hypoxia
Leading to Increased Transcription of HIF-1 Target Genes

                                      B.-H. Jiang et al.
                                      Am. J. Physiol.
                                      1996;271:C1172




                                                           % O2
                   Venous PO2   Arterial PO2
                   ~40 mm Hg    ~100 mm Hg


HIF-1 Mediates Homeostatic Responses to Reduced O2 Levels




                    > 4,000 Target Genes


HIF-1α is Required for Development of the Circulatory System

                   Heart                                                                Yolk sac




                                                                          Blood
+/+                      -/-
                                                                           Blood
                                                                                         Embryo
            Blood Vessels




                 +/+                             -/-
   N. V. Iyer et al., Genes Dev. 12: 149, 1998         D. Yoon et al., J. Biol. Chem. 281:25703, 2006


 HIF-1α, HIF-2α and HIF-3α Heterodimerize
 with HIF-1β and Activate Gene Transcription


    HIF-1           HIF-2           HIF-3
     H   H          H   H           H   H
     I   I          I   I           I   I
     F   F          F   F           F   F
     1   1          2   1           3   1
     α   β          α   β           α   β




All nucleated     Certain cell    Certain cell
 cell types of      types of        types of
~all metazoan      vertebrate      vertebrate
   species          species         species


Congenital Polycythemia (Too Many Red Cells)
  is Caused by Mutations in the HIF Pathway
                         Red blood cell production

                                    EPOR
                Type 4
                HIF2α                  EPO
             Gain of Function                      Type 1
                                                   EPOR
                                    HIF-1α      Gain of Function
                                    HIF-2α
         Type 2                    O2    PHD2
          VHL
      Loss of function               HIF-α
                                    Pro-OH                    Type 3
                                                              PHD2
                                 VHL                       Loss of function
                                     HIF-α
                                    Pro-OH
                                    Lys-Ubin


                                HIF degradation


Control of Red Blood Cell Production




      Cardiovascular Disease




              Cancer


   Cardiovascular Disease is the Leading Cause of Death
                In the Industrialized World




CORONARY ARTERY      CHEST PAIN
                    HEART ATTACK
                                        stenosis


PERIPHERAL ARTERY    LEG PAIN
                    AMPUTATION


   Cardiovascular Disease is the Leading Cause of Death
                In the Industrialized World




CORONARY ARTERY      CHEST PAIN
                    HEART ATTACK



PERIPHERAL ARTERY    LEG PAIN
                    AMPUTATION


                     Critical Limb Ischemia:
              End-Stage Peripheral Arterial Disease



Critical Limb Ischemia
                                                             stenosis
Perfusion is not sufficient to maintain
tissue viability, leading to:

Ischemic pain at rest
                                                collateral
Ischemic ulcers

Gangrene

Limb amputation


Analysis of Vascularization after Femoral Artery Ligation in
Wild-type (WT) and Heterozygous HIF-1α−Null (HET) Mice
    Ischemic:Non-ischemic Limb Perfusion Ratio   1.20
                                                                       Laser Doppler Perfusion Imaging

                                                 1.00


                                                 0.80
                                                                                                                    WT
                                                                                                                            2 mon old
                                                                                                                    HET
                                                 0.60
                                                                                                                    WT
                                                                                                                            8 mon old
                                                                                                                    HET
                                                 0.40

                                                                                                                    WT
                                                                                                                            20 mon old
                                                                                                                    HET
                                                 0.20


                                                 0.00
                                                        Pre-   Post-       3        7       14       21   28   35
                                                        Op      Op
                                                                                 Time (days)                    M. Bosch-Marcé et al.
                                                                                                               Circ. Res. 2007;101:1310


Additive Effects of Aging and Hif1a Genotype on Limb Salvage

               120


               100                                                                              Limb salvage
                                                                                                BAA/necrosis
% of Animals in Group




                        80                                                                      AAA


                        60


                        40


                        20


                         0

                               WT               HET            WT               HET             WT                HET

                             (n = 10)           (n = 9)      (n = 10)          (n = 15)        (n = 7)           (n = 8)


                                        2 mon old                       8 mon old                        20 mon old



                                             M. Bosch-Marcé et al., Circ. Res. 2007;101:1310


            Effects of Aging and Hif1a Genotype on
            Ischemia-induced HIF-1α Protein Levels




                 2-month-old                       8-month-old                 20-month-old

                WT              HET           WT            HET               WT               HET

          NIS        ISC      NIS     ISC   NIS    ISC    NIS     ISC   NIS        ISC   NIS         ISC

HIF-1α


β-actin




                           M. Bosch-Marcé et al., Circ. Res. 2007;101:1310


Improved Recovery of Perfusion in Mice by HIF-1α Gene Therapy
                         1.2
                                          AdLacZ
                                                                  2-month-old
                                                             **
  Limb Perfusion Ratio


                         1.0              AdCA5
                                                                  C57BL/6J mice
                         0.8
                                                        *         Ad: 6x108 pfu

                         0.6

                         0.4

                         0.2

                         0.0
                               Pre Post     3     7     14   21
                                          Time (days)




                                                                                   M. Bosch-Marcé et al.
                                                                                  Circ. Res. 2007;101:1310


Improved Recovery of Perfusion in Mice by HIF-1α Gene Therapy
                         1.2
                                          AdLacZ
                                                                  2-month-old
                                                             **
  Limb Perfusion Ratio


                         1.0              AdCA5
                                                                  C57BL/6J mice
                         0.8
                                                        *         Ad: 6x108 pfu

                         0.6

                         0.4

                         0.2

                         0.0
                               Pre Post     3     7     14   21
                                          Time (days)

                         1.2
                                          AdLacZ
                         1.0
  Limb Perfusion Ratio




                                          AdCA5

                         0.8

                         0.6                                 **
                         0.4
                                                                  8-month-old
                         0.2                                      C57BL/6J mice
                                                                  Ad: 2x108 pfu
                         0.0                                                       M. Bosch-Marcé et al.
                               Pre Post     3     7     14   21
                                          Time (days)                             Circ. Res. 2007;101:1310


Improved Recovery of Perfusion in Mice by HIF-1α Gene Therapy
                         1.2
                                          AdLacZ
                                                                  2-month-old
                                                             **
  Limb Perfusion Ratio


                         1.0              AdCA5
                                                                  C57BL/6J mice
                         0.8
                                                        *         Ad: 6x108 pfu

                         0.6

                         0.4

                         0.2
                                                                       AdCA5 gene therapy corrects age-related
                         0.0                                               impairment of vascularization
                               Pre Post     3     7     14   21
                                          Time (days)

                         1.2
                                          AdLacZ
                         1.0
  Limb Perfusion Ratio




                                          AdCA5

                         0.8

                         0.6                                 **
                         0.4
                                                                  8-month-old
                         0.2                                      C57BL/6J mice
                                                                  Ad: 2x108 pfu
                         0.0                                                                  M. Bosch-Marcé et al.
                               Pre Post     3     7     14   21
                                          Time (days)                                        Circ. Res. 2007;101:1310


 HIF-1 Regulates the Expression of Angiogenic Growth Factors
                          Hypoxia/Ischemia


                       Increased HIF-1 Activity




SDF1    SCF     PLGF       VEGF       EPO         ANGPT1      ANGPT2       PDGFB




CXCR4   C-KIT   VEGF-R1      VEGF-R2 EPOR              TIE2            PDGF-R



 Mobilization and          EPC Recruitment,                Modulation of
  Recruitment of        EC Proliferation/Survival,            EC-SMC
MSCs and BMDACs                Activation                   Interactions


                    Increased Tissue Vascularization


 HIF-1 Regulates the Expression of Angiogenic Growth Factors
                           Hypoxia/Ischemia


         Aging          Increased HIF-1 Activity




SDF1    SCF      PLGF      VEGF       EPO          ANGPT1     ANGPT2        PDGFB




CXCR4   C-KIT    VEGF-R1     VEGF-R2 EPOR              TIE2             PDGF-R



 Mobilization and          EPC Recruitment,                 Modulation of
  Recruitment of        EC Proliferation/Survival,             EC-SMC
MSCs and BMDACs                Activation                    Interactions


                    Increased Tissue Vascularization


 HIF-1 Regulates the Expression of Angiogenic Growth Factors
                           Hypoxia/Ischemia


         Aging          Increased HIF-1 Activity             AdCA5




SDF1    SCF      PLGF      VEGF       EPO          ANGPT1     ANGPT2        PDGFB




CXCR4   C-KIT    VEGF-R1     VEGF-R2 EPOR              TIE2             PDGF-R



 Mobilization and          EPC Recruitment,                 Modulation of
  Recruitment of        EC Proliferation/Survival,             EC-SMC
MSCs and BMDACs                Activation                    Interactions


                    Increased Tissue Vascularization


Control of Red Blood Cell Production




      Cardiovascular Disease




              Cancer


         Advanced Human Cancers Commonly Contain
               Regions of Intratumoral Hypoxia




Direct measurements of O2 concentration
in human tumors have demonstrated that
    PO2 < 10 mm Hg is associated with a
    significantly increased risk of invasion,
       metastasis, and patient mortality.




                                                HIF-1α
                                                expression by hypoxic cancer cells


HIF-1α Overexpression is Associated with Patient Mortality


   HIF Inhibitor Acriflavine Inhibits Tumor Growth and
  Vascularization in a Mouse Model of Prostate Cancer




Acriflavine (ACF) inhibits
 dimerization of HIF-α
  and HIF-1β subunits




       K. Lee et al.
Proc. Natl. Acad. Sci. USA
      2009;106:2353


HIF Inhibitor Digoxin Decreases Primary Tumor Growth
  and Metastasis in a Mouse Model of Breast Cancer

                                                                        Lung metastasis

                                                  Lymph node
  Primary tumor growth                            metastasis




                                Tumor cell area
                                 in axillary LN
                                                  Saline Digoxin




                    H. Zhang et al. Oncogene 2012;31:1757
           L. Schito et al. Proc. Natl. Acad. Sci. USA 2012;109:E2707
                   C.C. Wong et al. J. Mol. Med. 2012;90:803


Treatment with Gemcitabine + HIF Inhibitor Digoxin
           Causes Tumor Eradication



                                               No treatment
      Tumor volume




                                                           Gemcitabine

                                                       Gemcitabine
                                                       + Digoxin
                     Days after injection of tumor cells




      D. Samanta et al. Proc. Natl. Acad. Sci. USA 2014;111:E5429


                                                                                D Samanta et al. PNAS 2018;115:E1239
                                                                                    H Lu et al. Cell Rep 2017;18:1946

                    Deconvoluting the Role of HIFs                             D Samanta et al. Cancer Res 2016;76:4430
                                                                                 C Zhang et al. PNAS 2016;113:E2047

                     in Breast Cancer Metastasis
                                                                                C Zhang et al. Oncotarget 2016;7:64527
                                                                                 H Zhang et al. PNAS 2015;112:E6215
                                                                                    H Lu et al. PNAS 2015;112:E4600
                                                                                D Samanta et al. PNAS 2014;111:E5429
                                                                                 L Xiang et al. Oncotarget 2014;5:12509
                                                                                  T Wang et al. PNAS 2014;111:E3234
                                                                                 DM Gilkes et al. PNAS 2014;111:E384
                                                                                  L Xiang et al. J Mol Med 2014;92:151
                                                                               P Chaturvedi et al. PNAS 2014;111:E2120
MSC/Mφ Cooptation                                                              DM Gilkes et al. Cancer Res 2013;73:3285
  CXCR3, CCR5                                                                 DM Gilkes et al. Mol Cancer Res 2013;11:456
                                                                              P Chaturvedi et al. J Clin Invest 2013;123:189
CXCL16, PGF, CSF1                                                                 L Schito et al. PNAS 2012;109:E2707
                  Migration/Invasion                                            CC Wong et al. J Mol Med 2012;90: 803
                                                                                H Zhang et al. Oncogene 2012;31:1757
                Microvesicle Formation                                           CC Wong et al. PNAS 2011;108:16369
                   RHOA, ROCK1
                P4HA1, P4HA2, PLOD2
                       RAB22A            Margination/
                                         Extravasation
                                           L1CAM,
                                          ANGPTL4         Immune Evasion
                                                         CD47, CD73, PDL1


                                                                            Premetastatic Niche
                                                                                Formation
                                                                            LOX, LOXL2, LOXL4

                                                                                                        Cancer Stem Cell
                                                                                                             Specification
                                     HIF-1α                                                               WWTR1, SIAH1
                                                                                                   IL6, IL8, MDR1, CD47
                                     HIF-1β                                                              SLC7A11, GCLM
                                                                                                       ALKBH5, ZNF217,
                                                                                                         PHGDH, GSTO1


 HIFs Mediate                       GSTO1                     SLC7A11
 Breast Cancer                                      CD73          GCLM
   Stem Cell                         RYR1
  Specification                           Ca2+
                                                     Ado          GSH
                                                                     Cu
In Response to                       PYK2           A2BR          MEK
   Hypoxia or
Chemotherapy                          SRC            PKCδ         ERK         DUSP9          REST
                              IL6

                                     STAT3                        FOXO3                     DUSP16

                             JAK2
                                                 NANOG mRNA
                                                  transcription                             p38MAPK

                   ALKBH5
                                                 NANOG mRNA
                                    m6A                                   ZFP36L1             MK2
                                                    stability
                    ZNF217

                                                    NANOG


 C. Zhang, PNAS 2016;113:E2047                                                   H. Lu, PNAS 2015;112:E4600
C. Zhang, Oncotarget 2016;7:64527
                                         Breast cancer stem cell                H. Lu, Cancer Res 2018;78:4191
   H. Lu, Cell Rep 2017;18:1946       specification and self-renewal             J. Lan, PNAS 2018;115:E9640


                                       T lymphocyte
  Innate                                              Anergy/death
 immunity                  Adaptive
                           immunity

                                                      A2A

                                 AMP     Ado                 PD-1
                                                             PDL1
                                      CD73


             SIRPα CD47
                                      HIFs
Phagocytosis
                                                                     C
               LRP   CRT
                                                                     H
                                 Breast cancer cell                  E
Macrophage                                                           M
             Chemotherapy-Induced & HIF-Dependent
             Evasion of Innate and Adaptive Immunity                 O


      HIF Pathway in Biology and Medicine


1. Development: HIF-1α, HIF-1β, HIF-2α, PHD2, and VHL are
   all required for normal mammalian embryonic development.

2. Physiology: Even modest gain or loss of function of pathway
   components interferes with normal postnatal physiological
   responses to hypoxia (congenital polycythemia).

3. Medicine: HIFs play key roles in cancer and cardiovascular
   disease, the major causes of mortality in the U.S. population.
   Clinical trials are planned or underway to evaluate novel
   therapies that target HIFs for inhibition (cancer, retinopathy)
   or activation (anemia, cardiovascular disease).

4. Evolution: HIF-1α, HIF-1β, PHD, and VHL homologs are
   found in all metazoan species. Genetic evidence implicates
   the HIF pathway as the critical genetic target for successful
   adaptation to high altitude in Tibetan and Andean
   populations.


Acknowledgments




                                               Haig Kazazian      Stylianos Antonarakis    Victor McKusick




                 Rose Nelson



                                                   Larissa Shimoda        Akrit Sodhi     Nanduri Prabhakar




 John Gearhart     Thomas Kelly   Guang Wang
                                                       Chi Dang           Josef Prchal     Mike Armstrong


Acknowledgments


Guang Wang              Xiaofei Wei          Tina Huang             Stelios Antonarakis   Josef Prchal
Raquel Dureza           Shaoping Chen        Wendy Xie              Haig Kazazian         Christian Bauer
Bing-Hua Jiang          Rigu Gupta           Haiquan Lu             John Gearhart         Agata Giallongo
Narayan Iyer            David Qian           Caroline Vissers       Tom Kelly             Roger Johns
Lori Kotch              Huafeng Zhang        Linh Tran              Augustine Choi        Lowell Davis
Aimee Yu                KangAe Lee           Walter Jackson         Mike Kastan           Stella Kourembanas
Faton Agani             Yee Sun Tan          Shaima Salman          Jonathan Simons       Kurt Stenmark
Erik Laughner           Kakali Sarkar        Yongkang Yang          Larissa Shimoda       David Zagzag
Sandra Leung            Sergio Rey           Yufeng Wang            Charles Wiener        Frank Sharp
Brian Kelly             Weibo Luo            Yajing Lyu             Jim Sylvester         Elsken van der Wall
Kiichi Hirota           Hong Wei             Ru Wang                Raj Ratan             Daniel Aebersold
Hiroaki Okuyama         Maimon Hubbi         Yiwei Ai               Peter Campochiaro     Rubin Tuder
Ashley Rowan            Hongxia Hu           Yayun Zhu              Atul Bedi             Jeffrey Isner
Sharon Berg-Dixon       Ryan Chang           Chelsey Chen           Jay Zweier            Nanduri Prabhakar
Ryo Fukuda              Jasper Chen          Rima Shah              Angelo DeMarzo        Mikhail Sitkovsky
Balaji Krishnamachary   Stephen Pitcairn     Sophia Lee             Skip Garcia           Lee Ellis
Connor Mahon            Ting Wang            Naveena Murugan        Jon Resar             Shinae Kizaka-Kondoh
Jane Oh                 Pallavi Chaturvedi   Kazuyo Yamaji-Keegan   Rusty Hofmann         Kiichi Hirota
Dom Manalo              Naoharu Takano       David Kass             Seva Polotsky         Hua Yu
Yifu Zhou               Daniele Gilkes       Kathy Gabrielson       David Huso            Michal Horowitz
Karen Rainey            Sun Joo Lee          Jenny van Eyk          Bob Cole              Michael Hadjiargyrou
Jake Wesley             John Bullen          Denis Wirtz            Chi Dang              Michiko Watanabe
Hideko Nagasawa         Youngrok Park        Jordan Green           John Harmon           Bob Kerbel
Hideo Kimura            Ivan Chen            Ed Gabrielson          Steve Georas          Theresa LaValle
Zheqing Cai             Lisha Xiang          Sol Snyder             Roberto Pili          Ye Sun
Hua Zhong               Huimin Zhang         Fan Pan                Jun Liu               Frank Gonzalez
Jin Baek                Chuanzhao Zhang      Cindy Zahnow           Charles Steenbergen   Charles Graham
Ye Liu                  Debangshu Samanta    Akrit Sodhi            Akhilesh Pandey       Najie Jing
Marta Bosch-Marce       Jie Lan              David Meyers           Andre Levchenko       Gerd Schmitz
